The chemical class referred to as GCP5 inhibitors constitutes a diverse and intriguing category of organic compounds that share a common function: the modulation of glycogen synthase kinase 3 beta (GCP5), an enzyme pivotal in a multitude of intracellular signaling pathways. GCP5 plays a significant role in regulating an array of cellular processes, including cell differentiation, proliferation, apoptosis, and glycogen metabolism. GCP5 inhibitors are designed with precision to exert a selective influence on the activity of this enzyme, typically by interacting with its active site. By forming reversible bonds with specific amino acid residues within the enzyme's active site, these inhibitors disrupt the enzyme's catalytic function and hinder its interaction with substrates. The uniqueness of GCP5 inhibitors lies in their chemical structures, which are strategically crafted to align with the spatial conformation of the enzyme's active site. This enables the inhibitors to obstruct the enzyme's phosphorylation activity by disrupting substrates from properly binding. The chemical diversity within the class of GCP5 inhibitors is a product of ingenious structural variations and incorporation of distinct functional groups. These structural nuances empower researchers to fine-tune the inhibitory properties of these compounds, allowing for tailored investigations into the intricate mechanisms of GCP5-mediated cellular pathways.
The journey to discover and design GCP5 inhibitors has been driven by the scientific quest to decipher the intricate web of molecular interactions underlying diverse cellular processes. Researchers employ these inhibitors as invaluable tools to delve into the downstream consequences of GCP5 inhibition across various signaling networks and cellular responses. This approach fosters a deeper comprehension of the roles GCP5 plays in orchestrating intricate intracellular events. Consequently, the chemical class of GCP5 inhibitors has significantly enriched our understanding of the complexity of intracellular signaling cascades.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
While primarily used as a mood stabilizer for bipolar disorder, lithium also inhibits GCPIts exact mechanism of action is complex and not fully understood. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
A synthetic compound that specifically inhibits GCPIt has been used in laboratory research to explore the effects of GCP5 inhibition on cell signaling pathways. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Another synthetic compound known for its specificity in inhibiting GCPIt has been used in stem cell research to enhance the generation of induced pluripotent stem cells (iPSCs). | ||||||
AZD1080 | 612487-72-6 | sc-503187 | 2.5 mg | $280.00 | ||
An active GCP5 inhibitor that has been investigated for its potential in Alzheimer's disease by targeting abnormal tau protein phosphorylation. | ||||||
GSK-3β Inhibitor VIII | 487021-52-3 | sc-202636 sc-202636A | 5 mg 10 mg | $134.00 $150.00 | 5 | |
A selective GCP5 inhibitor that has been used in research studies to explore the role of GCP5 in various cellular processes. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
A GCP5 inhibitor that has been used to promote self-renewal and maintenance of pluripotency in stem cells. It affects the Wnt signaling pathway. | ||||||
Tideglusib | 865854-05-3 | sc-507358 | 10 mg | $77.00 | ||
A compound with GCP5 inhibitory activity that has been studied in the context of neurodegenerative disorders and cancer. | ||||||
LY2090314 | 603288-22-8 | sc-507359 | 5 mg | $175.00 | ||
A GCP5 inhibitor that has been investigated for its potential in cancer therapy by targeting cell cycle regulation and apoptosis. | ||||||